---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-000719"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2025-04-29T23:59:59+00:00"
generated_at: "2026-05-23T03:50:22.837040+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences receives Nasdaq minimum bid price deficiency notice; 180-day cure period until Oct 20, 2025

## Summary
- Received Nasdaq notice on April 23, 2025 for non-compliance with $1.00 minimum bid price requirement.
- Must regain compliance by Oct 20, 2025; closing bid price must meet or exceed $1.00 for 10 consecutive business days.
- Possible second 180-day extension if other listing standards met; company may implement a reverse stock split.
- No immediate effect on listing; company intends to monitor bid price and evaluate available options.

## SEC filing metadata
- accession: 0001640334-25-000719
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2025-04-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033425000719/0001640334-25-000719-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033425000719/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-000719
- JSON: https://secwatch.observer/filing/0001640334-25-000719.json
- Plain text: https://secwatch.observer/filing/0001640334-25-000719.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.